What are the Ebola vaccines under research, and when will they be ready?
Summary
East Africa is facing a fast-spreading Ebola outbreak caused by a rare strain called Bundibugyo. The outbreak started in eastern Democratic Republic of the Congo (DRC) and has spread to Uganda, with hundreds infected and dozens dead. There is currently no approved vaccine for this strain, though three vaccines are being tested.Key Facts
- The Ebola outbreak began in May 2026 in Ituri province, eastern DRC, an area affected by armed conflict.
- By early June, there were over 300 confirmed cases and 48 deaths in the DRC.
- Uganda has reported at least 15 cases and one death, with infections reaching its capital, Kampala.
- The Bundibugyo Ebola virus strain causes death in about 30-50% of cases and is rarer than the Zaire strain.
- Vaccines exist for the more common Zaire strain but none are yet approved for Bundibugyo.
- Three new vaccines for Bundibugyo are under research and planned to be fast-tracked for trials.
- Conflict and limited healthcare resources in the region make controlling the outbreak difficult.
- Cuts in international aid, including U.S. foreign aid reductions last year, have weakened the response efforts.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.